About Index Trending news
Analyze
Pricing
Sequenta

Sequenta

Work at Sequenta? Add yourself to this profile

Sequenta

is dedicated to improving patient care in diseases mediated by immune cells. Our ClonoSIGHT™ test for MRD in lymphoid cancers launched in 2013.
Edit Profile
More info

Elsewhere

Also headquartered in San Francisco

Twitter Twitter Uber Uber Instagram Instagram Airbnb Airbnb Lyft Lyft Reddit Reddit Salesforce Salesforce Fitbit Fitbit TechCrunch TechCrunch Slack Slack

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
20 Oct 2014
Venture capital
Celgene
Added by

Celgene Participates in New Round of Investment for Sequenta

businesswire
02 Jul 2013
$20,000,000
Venture capital (Series C)
Foresite Capital
01 Jan 2012
$8,460,000
Undisclosed funding
Index Ventures, Mohr Davidow Ventures
08 Dec 2010
$13,000,000
Venture capital (Series B)
Jacob Goldfield